Anti-Neurofascin Antibodies Associated with White Matter Diseases of the Central Nervous System: A Red Flag or a Red Herring?

Anti-Neurofascin Antibodies Associated with White Matter Diseases of the Central Nervous System: A Red Flag or a Red Herring?

Autoantibodies against nodal and paranodal proteins, specifically anti-neurofascin antibodies (ANFAs), have been recently described in central and peripheral nervous system demyelinating disorders. We retrospectively reviewed the charts of six individuals evaluated at our Multiple Sclerosis Program...

Full description

Bibliographic Details
Main Authors:	Navnika Gupta, Afsaneh Shirani, Lakshman Arcot Jayagopal, Ezequiel Piccione, Elizabeth Hartman, Rana Khalil Zabad
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	Brain Sciences
Subjects:	anti-neurofascin antibodies nodes of Ranvier paranodes demyelinating diseases combined central and peripheral demyelination multiple sclerosis
Online Access:	https://www.mdpi.com/2076-3425/12/9/1124

Similar Items

Pathophysiology of Chronic Inflammatory Demyelinating Polyneuropathy: Insights into Classification and Therapeutic Strategy
by: Haruki Koike, et al.
Published: (2020-05-01)

Implication of Contactins in Demyelinating Pathologies
by: Ilias Kalafatakis, et al.
Published: (2021-01-01)

Different binding and pathogenic effect of neurofascin and contactin–1 autoantibodies in autoimmune nodopathies
by: Katharina Hecker, et al.
Published: (2023-06-01)

Macrophages and Autoantibodies in Demyelinating Diseases
by: Haruki Koike, et al.
Published: (2021-04-01)

Chronic inflammatory demyelinating polyradiculoneuropathy with antineurofascin-155 antibodies: A first case report in Peru
by: Darwin Segura-Chávez, et al.
Published: (2023-01-01)

Case report: Anti-CNTN1 antibody-associated nodopathies disease with asymmetric onset
by: Qian Li, et al.
Published: (2023-03-01)

Case report: Autoimmune nodopathy with concurrent serum and CSF IgG4 anti-neurofascin 155 antibodies
by: Wanyu Wang, et al.
Published: (2022-09-01)

Immunoadsorption and Plasma Exchange in Seropositive and Seronegative Immune-Mediated Neuropathies
by: Alexander J. Davies, et al.
Published: (2020-06-01)

Measuring disease activity and predicting response to intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy
by: Anthony Khoo, et al.
Published: (2019-02-01)

Case report: Amnestic mild cognitive impairment in multiple domains associated with neurofascin 186 autoantibodies: Case series with follow-up and review
by: Niels Hansen, et al.
Published: (2023-01-01)

Red Flags for Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated with Sarcoidosis or Connective Tissue Diseases
by: Clément Vialatte de Pémille, et al.
Published: (2023-05-01)

Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody
by: Yunfei Bai, et al.
Published: (2023-03-01)

Fulminant inflammatory demyelination presenting as stroke‐in‐evolution in an elderly subject
by: Simone Sacco, et al.
Published: (2021-08-01)

Microglia influence immune responses and restrict neurologic disease in response to central nervous system infection by a neurotropic murine coronavirus
by: Amber Syage, et al.
Published: (2023-11-01)

Postprandial hyperglycaemia: Red herring or red flag?
by: Karamat, M, et al.
Published: (2010)

Blood-nerve barrier disruption and coagulation system activation induced by mechanical compression injury participate in the peripheral sensitization of trigeminal neuralgia
by: Lu-Xi Zhou, et al.
Published: (2022-12-01)

Acute combined central and peripheral nervous system demyelination: a case report
by: Young Eun Roh, et al.
Published: (2018-12-01)

Dual Mechanism of Action of Curcumin in Experimental Models of Multiple Sclerosis
by: Ines ELBini-Dhouib, et al.
Published: (2022-08-01)

Cognitive impairment in clinically isolated syndromes: A control-case study
by: Mohamed Islam KEDIHA, et al.
Published: (2020-06-01)

Recurrent tumefactive demyelinating lesions in an elderly woman
by: Erika L. Weil, MD, et al.
Published: (2022-12-01)

Cognitive impairment in clinically isolated syndromes: A control-case study
by: Mohamed Islam KEDIHA, et al.
Published: (2020-06-01)

Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery
by: Feng Mei, et al.
Published: (2016-09-01)

Anti-NF155/NF186 IgG4 Antibody Positive Autoimmune Nodopathy
by: Lijun Wang, et al.
Published: (2022-11-01)

The establishment and application of MOG-IgG-mediated complement-dependent in vitro demyelination model
by: Chen Yashuang, Xiao Xiuqing, Wang Shisi, Mo Yongxin, Sun Xiaobo, Zhong Xiaofen, Peng Lisheng
Published: (2022-03-01)

Hesperidin plays beneficial roles in disorders associated with the central nervous system: a review
by: Ayomide Victor Atoki, et al.
Published: (2023-09-01)

Hymenoptera sting as atypical causative factor for Guillain Barré Syndrome and chronic inflammatory demyelinating polyneuropathy – A case report and insights on pathophysiology
by: Cristina Gatcan, et al.
Published: (2023-12-01)

The role and potential therapeutic targets of astrocytes in central nervous system demyelinating diseases
by: Rui Tan, et al.
Published: (2023-09-01)

Clinical and Prognostic Evaluation of Myelin Oligodendrocyte Glycoprotein Autoimmunity in the Central Nervous System
by: Volkan Taşdemir, et al.
Published: (2018-12-01)

Demyelinating Disease? Central Nervous System Lymphoma?
by: Ufuk Ergün, et al.
Published: (2008-06-01)

Intranasal Resveratrol Nanoparticles Enhance Neuroprotection in a Model of Multiple Sclerosis
by: Ehtesham Shamsher, et al.
Published: (2024-04-01)

Defective Oligodendroglial Lineage and Demyelination in Amyotrophic Lateral Sclerosis
by: Elisabeth Traiffort, et al.
Published: (2021-03-01)

The Role of Non-Selective TNF Inhibitors in Demyelinating Events
by: Line Buch Kristensen, et al.
Published: (2021-01-01)

Myelination synchronizes cortical oscillations by consolidating parvalbumin-mediated phasic inhibition
by: Mohit Dubey, et al.
Published: (2022-01-01)

Prevalence of neurodegenerative/demyelinating disorders in patients with achalasia
by: Jerie Martin, et al.
Published: (2022-10-01)

Acute Demyelinating Disease after Oral Therapy with Herbal Extracts
by: Alex Kostianovsky, et al.
Published: (2011-06-01)

Intrathecal Dexmedetomidine for Anaesthetic Management of a Patient with Chronic Inflammatory Demyelinating Polyneuropathy
by: S Bala Bhaskar, et al.
Published: (2016-09-01)

Central nervous system demyelinating diseases: glial cells at the hub of pathology
by: Vinicius Gabriel Coutinho Costa, et al.
Published: (2023-05-01)

Protein Tyrosine Phosphatase Receptor Type Z in Central Nervous System Disease
by: Kenichiro Nagai, et al.
Published: (2022-04-01)

Secondary Central Nervous System Demyelinating Disorders in the Elderly: A Narrative Review
by: Christos Bakirtzis, et al.
Published: (2023-07-01)

Case report: Recovery and sequential imaging of a patient with osmotic demyelination syndrome
by: Stephanie Harris, et al.
Published: (2023-04-01)